Display Settings:

Format

Send to:

Choose Destination
Clin Infect Dis. 2014 Feb;58(4):537-9. doi: 10.1093/cid/cit719. Epub 2013 Oct 30.

Hypersensitivity reactions associated with fidaxomicin use.

Author information

  • 1Division of Anti-Infective Products, Food and Drug Administration, Silver Spring, Maryland.

Abstract

We report hypersensitivity reactions associated with fidaxomicin, an antibacterial drug approved for the treatment of Clostridium difficile-associated diarrhea. These reactions are viewed as significant because of severity and unexpected because fidaxomicin is minimally absorbed. The fidaxomicin labeling was revised to include information about the possibility of hypersensitivity reactions.

KEYWORDS:

adverse reactions; fidaxomicin; hypersensitivity

PMID:
24178248
[PubMed - in process]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for HighWire
    Loading ...
    Write to the Help Desk